Vimarsana
Biggest News Aggregation in the World

Page 7 - Mc Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mc Services Today - Breaking & Trending Today

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th - Vimarsana News

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium...

Report on Carbios' liquidity contract with Natixis ODDO BHF -January 10, 2024 at 12:02 pm EST - Vimarsana News

Report on Carbios' liquidity contract with Natixis ODDO BHF -January 10, 2024 at 12:02 pm EST

Shares concerned: Carbios Market concerned: Euronext Growth Paris Clermont-Ferrand , 10 January 2024 . CARBIOS, , a pioneer in the development and industrialization of biological...

Mainz Biomed Provides Year-End Corporate Review 2023 - Vimarsana News

Mainz Biomed Provides Year-End Corporate Review 2023

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous09.01.2024 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Provides Year-End Corporate Review 2023 European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Co...

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approva - Vimarsana News

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approva

PREVYMIS® now approved in the U.S. and Europe for prophylaxis of Cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R‑])EMA approval triggers a €15 Million Milestone payment to AiCuris and AiCuris is eligible for further milestone p...

Mainz Biomed Provides Year-End Corporate Review 2023 - Vimarsana News

Mainz Biomed Provides Year-End Corporate Review 2023

Mainz Biomed Provides Year-End Corporate Review 2023...